HV
☆    

India,
2010-04-14 20:37
(5914 d 01:24 ago)

Posting: # 5136
Views: 3,880
 

 Truncated approach for NTI? [Design Issues]

Dear all,

There are a few narrow therapeutic index drugs with prolonged elimination half-life e.g. warfarin, tacrolimus, etc. These are the drugs for which usually tightended interval (90-111.11% for EU and 90-112% for HPFB) is applicable for AUC.
Is it possible to apply truncated approach (sampling till 72 hrs) for these molecules?

Thanks,
Heema Valera
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-04-14 20:48
(5914 d 01:14 ago)

@ HV
Posting: # 5137
Views: 3,192
 

 Why not?

Dear Heema,

Why do you think that it is not possible?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
HV
☆    

India,
2010-04-14 21:19
(5914 d 00:43 ago)

@ Helmut
Posting: # 5139
Views: 3,149
 

 Why not?

❝ Why do you think that it is not possible?


Dear Helmut,
thanks for prompt response!
i think so, because overall extent of absorption is of importance for such NTIs. And the truncated approach repesents only a fraction of total extent. Will you please share your thoughts on application of truncted area (AUC72) for NTIs as well?

Thanks,

Heema
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-04-14 21:38
(5914 d 00:24 ago)

@ HV
Posting: # 5141
Views: 3,139
 

 Absorption important

Dear Heema,

❝ [...] overall extent of absorption is of importance for such NTIs.


No, in BE we are interested in the difference of absorption between formulations. Elimination is specific for the drug. After 2-4× tmax the AUC-ratio does not change any more, only variability increases (just saw Kamal Midha walking 'round the corner ;-)). In other words AUC72(T)/AUC72(R) ~ AUC504(T)/AUC504(R) ~ AUCinf(T)/AUCinf(R), but AUC's CVintra,72<CVintra,504<CVintra,inf. Please search the forum for examples and references.

Above said is only true for immediate relase formulations (elimination = slowest phase). For some MR formulations (CR, but not DR) the slowest phase is absorption - the one we are interested in: in such a case truncation does not make sense. Luckily there are only a few stupid controlled release formulations of drug with a long half-life on the market.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
131 visitors (0 registered, 131 guests [including 33 identified bots]).
Forum time: 22:02 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5